Comment from Lupus Foundation of America

Summary: The Lupus Foundation of America supports the FDA's initiative to identify opportunities for drug repurposing, particularly for diseases with significant unmet needs and limited commercial incentives. They advocate for streamlined regulatory pathways that incorporate real-world evidence, patient registries, and collaborative public-good models to expand treatment options for lupus patients.